EPIDEL

Welcome to the Brand page for “EPIDEL”, which is offered here for Drug delivery systems, bioresponsive resorbable polymers containing pharmaceuticals and sold as a component of devices used in cardiovascular, urological, neurological and musculoskeletal applications, orthopedic, ear, nose, throat, dental, faciomaxilliary, neurosurgical, soft tissue replacement, intra-abdominal, thoracic, and ophthalmic implants, implants for repairing muscular or other tissue, or for augmenting, strengthening, or aiding muscular or other tissue in performing a function, surgical implants for bone, joint, and cartilage repair, connective tissue implants, stents, guide wires, and catheters, prosthetic devices, dialysis implants, pacemaker circuitry and heart valve implants;bioresponsive resorbable polymers for use in the manufacture of drug delivery systems;.

Its status is currently believed to be active. Its class is unavailable. “EPIDEL” is believed to be currently owned by “INTERFACE BIOLOGICS INC.”


Owner:
INTERFACE BIOLOGICS INC.
Owner Details
Description:
Drug delivery systems, bioresponsive resorbable polymers containing pharmaceuticals and sold as a component of devices used in cardiovascular, urological, neurological and musculoskeletal applications, orthopedic, ear, nose, throat, dental, faciomaxilliary, neurosurgical, soft tissue replacement, intra-abdominal, thoracic, and ophthalmic implants, implants for repairing muscular or other tissue, or for augmenting, strengthening, or aiding muscular or other tissue in performing a function, surgical implants for bone, joint, and cartilage repair, connective tissue implants, stents, guide wires, and catheters, prosthetic devices, dialysis implants, pacemaker circuitry and heart valve implants;Bioresponsive resorbable polymers for use in the manufacture of drug delivery systems;
Categories: DRUG DELIVERY SYSTEMS